...
首页> 外文期刊>Journal of applied toxicology >Preclinical risk assessment of drug-induced hypo- and hyperprolactinemia.
【24h】

Preclinical risk assessment of drug-induced hypo- and hyperprolactinemia.

机译:药物诱发的低泌乳素血症和高泌乳素血症的临床前风险评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Drug-induced changes in prolactin signaling may obscure interpretation of preclinical toxicological endpoints. However, with informed consideration, classic hallmarks of hypo-/hyperprolactinemia can be recognized in short- and long-term rodent bioassays. Findings can be supported and expanded with additional in vivo and in vitro datasets. When taken together with human epidemiological evidence pertaining to the consequences of drug-induced hypo-/hyperprolactinemia, such findings permit both an analysis of human relevance and an assessment of human risk.
机译:催乳素信号传导中的药物诱导的变化可能会模糊临床前毒理学终点的解释。然而,经过充分考虑,低/高催乳素血症的经典标志可以在短期和长期的啮齿动物生物测定中得到认可。研究结果可以通过其他体内和体外数据集得到支持和扩展。当与有关药物引起的低/高催乳素血症后果的人类流行病学证据一起使用时,这些发现既可以分析人类相关性,也可以评估人类风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号